Investigation of the relationship of frontal QRS-T angle and digoxin use and blood digoxin level

Year 2022, Volume: 8 Issue: 5, 685 - 694, 04.09.2022

İsmet Zengin , Berat Uğuz

https://doi.org/10.18621/eurj.1144126

Abstract

Objectives: Digoxin is an antiarrhythmic drug with a narrow therapeutic range and used in clinical conditions such as heart failure and atrial fibrillation. The planar frontal QRS-T angle reflects the deviations between the depolarization and repolarization of the ventricles, and it has been reported that an increase in this angle is associated with an increase in mortality. In our study, the relationship between frontal QRS-T angle and digoxin use and blood digoxin level was investigated.

Methods: The study included 105 digoxin users who used digoxin, whose levels were measured, who had an electrocardiogram (ECG) on the system, and 15 patients with similar characteristics, who had an ECG and did not use digoxin. Patients using digoxin and whose levels were measured were also divided into three groups as < 0.8 ng/mL, 0.8-1.2 ng/mL, and > 1.2 ng/mL. The absolute value of the value obtained by subtracting the axis of the T wave from the axis of the QRS angle indicated on the paper, calculated automatically on the 12-lead ECG, was accepted as the frontal QRS-T angle value.

Results: Planar frontal QRS-T angle measured by 12-lead ECG in digoxin users was 120º (55.5º-155.5º), while it was 106º (32º-163º) in non-users, and there was no statistical difference between the two groups (p = 0.833). In the evaluation made according to different blood drug levels as < 0.8 ng/mL, 0.8-1.2 ng/mL, > 1.2 ng/mL in digoxin users, no significant difference was observed between the frontal QRS-T angle between the groups (109.5° [60.25°-154.25°] for < 0.8 ng/mL, 136.5° [48.5°-158.5°] for 0.8-1.2 ng/mL, 117° [34°-154°] for 1.2 ng/mL) (p = 0.773).

Conclusions: There was no significant difference in frontal QRS-T angle between digoxin users and non-users. There was no significant relationship between different blood digoxin levels and frontal QRS-T angle.

Keywords

Frontal QRS-T angle, digoxin, digoxin level, intoxication, electrocardiogram

References

• 1. Macfarlane PW. The frontal plane QRS-T angle. Europace 2012;14:773-5.
• 2. Zhang X, Zhu Q, Zhu L, Jiang H, Xie J, Huang W, et al. Spatial/frontal QRS-T angle predicts all-cause mortality and cardiac mortality: a meta-analysis. PLoS One 2015;10:e0136174.
• 3. Aro AL, Huikuri HV, Tikkanen JT, Junttila MJ, Rissanen HA, Reunanen A, et al. QRS-T angle as a predictor of sudden cardiac death in a middle-aged general population. Europace 2012;14:872-6.
• 4. PM, Okin. Electrocardiography in women: taking the initiative. Circulation 2006;113:464-6.
• 5. Zhang ZM, Prineas RJ, Case D, Soliman EZ, Rautaharju PM, ARIC Research Group. Comparison of the prognostic significance of the electrocardiographic QRS/T angles in predicting incident coronary heart disease and total mortality (from the atherosclerosis risk in communities study). Am J Cardiol 2007;100:844-9.
• 6. Borleffs CJ, Scherptong RW, Man SC, van Welsenes GH, Bab JJ, van Erven L, et al. Predicting ventricular arrhythmias in patients with ischemic heart disease: clinical application of the ECG-derived QRS-T angle. Circ Arrhythm Electrophysiol 2009;2:548-54.
• 7. Bauman JL, Didomenico RJ, Galanter WL. Mechanisms, manifestations, and management of digoxin toxicity in the modern era. Am J Cardiovasc Drugs 2006;6:77-86.
• 8. Bhatia SJ, Smith TW. Digitalis toxicity: mechanisms, diagnosis, and management. J Card Surg 1987;2:453-65.
• 9. Virgadamo S, Charnigo R, Darrat Y, Morales G, Elayi CS. Digoxin: a systematic review in atrial fibrillation, congestive heart failure and post myocardial infarction. World J Cardiol 2015;7: 808-16.
• 10. Ferrari F, Santander IRMF, Stein R. Digoxin in atrial fibrillation: an old topic revisited. Curr Cardiol Rev 2020;16:141-6.
• 11. Griffin BP (ed). Manuel of Cardiovascular Medicine, 4th ed. Lippincott Williams & Wilkins., 2012.
• 12. Mladěnka P, Applová L, Patočka J, Costa VM, Remiao F, Pourová J, et al. Comprehensive review of cardiovascular toxicity of drugs and related agents. Med Res Rev 2018;38:1332-403.
• 13. Djohan AH, Sia CH, Singh D, Lin W, Kong WK, Poh KK. A myriad of electrocardiographic findings associated with digoxin use. Singapore Med J 2020;61:9-14.
• 14. Oehler A, Feldman T, Henrikson CA, Tereshchenko LG. QRS-T angle: a review. Ann Noninvasive Electrocardiol 2014;19: 534-54.
• 15. Erdogan G, Yontar OC, Yenercag M, Gul S, Arslan U. Frontal QRS-T angle predicts syntax score in patients with non-ST elevation myocardial infarction. J Electrocardiol 2020;61:86-91.
• 16. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
• 17. Turakhia MP, Santangeli P, Winkelmayer WC, Xu X, Ullal AJ, Than CT, et al. Increased mortality associated with digoxin in contemporary patients with atrial fibrillation: findings from the TREAT-AF study. J Am Coll Cardiol 2014;64:660-8.
• 18. Whitbeck MG, Charnigo RJ, Khairy P, Ziada K, Bailey AL, Zegarra MM, et al. Increased mortality among patients taking digoxin--analysis from the AFFIRM study. Eur Heart J 2013;34:1481-8.
• 19. Lopes RD, Rordorf R, De Ferrari GM, Leonardi SL, Thomas L, Wojdyla DM, et al. Digoxin and mortality in patients with atrial fibrillation. J Am Coll Cardiol 2018;71:1063-74.
• 20. Rathore SS, Curtis JP, Wang Y, Bristow MR, Krumholz HM. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 2003;289:871-8.
• 21. Patocka J, Nepovimova E, Wu W, Kuca K. Digoxin: pharmacology and toxicology-A review. Environ Toxicol Pharmacol 2020;79:103400.
• 22. Giovanardi P, Vernia C, Tincani E, Giberti C, Silipo F, Fabbo A. Combined effects of age and comorbidities on electrocardiographic parameters in a large non-selected population. J Clin Med 2022;11:3737.
• 23. Zyoud SH, Waring WS, Al-Jabi SW, Sweileh WM. Bibliometric profile of global scientific research on digoxin toxicity (1849-2015). Drug Chem Toxicol 2020;43:553-9.
• 24. Thiemann DR. Digitalis and hemodialysis are a bad combination. J Am Soc Nephrol 2010;21:1418-20.
• 25. García-Iranzo EM, Rodríguez-Lucena FJ, Matoses-Chirivella C, García-Monsalve A, Murcia-López AC, Navarro-Ruiz A. Pharmacokinetic monitoring of chronic treatment with digoxin from Primary Health Care. Farm Hosp 2017;41:527-32.
• 26. Chan KE, Lazarus JM, Hakim RM. Digoxin is associates with mortality in ESRD. J Am Soc Nephrol 2010;21:1550-9.